Home > Insider Trading > Filing (0001127602-21-028290)

Filing Details

Accession Number:: 0001127602-21-028290
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-03 16:34:49
Reporting Period:: 2021-11-02

Accepted Time:: 2021-11-03 16:34:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
97745	Thermo Fisher Scientific Inc.	TMO	Measuring & Controlling Devices, Nec (3829)	042209186

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1648929	Stephen Williamson	168 Third Avenue Waltham MA 02451	Sr. Vp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-11-02	22,550	$129.77	62,771	No	4	M	Direct
Common Stock	Disposition	2021-11-02	300	$633.26	62,471	No	4	S	Direct
Common Stock	Disposition	2021-11-02	400	$634.42	62,071	No	4	S	Direct
Common Stock	Disposition	2021-11-02	3,717	$635.73	58,354	No	4	S	Direct
Common Stock	Disposition	2021-11-02	4,085	$636.73	54,269	No	4	S	Direct
Common Stock	Disposition	2021-11-02	3,645	$637.87	50,624	No	4	S	Direct
Common Stock	Disposition	2021-11-02	4,760	$638.97	45,864	No	4	S	Direct
Common Stock	Disposition	2021-11-02	3,159	$639.98	42,705	No	4	S	Direct
Common Stock	Disposition	2021-11-02	1,684	$640.92	41,021	No	4	S	Direct
Common Stock	Disposition	2021-11-02	700	$642.03	40,321	No	4	S	Direct
Common Stock	Disposition	2021-11-02	100	$642.88	40,221	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-11-02	22,550	$0.00	22,550	$129.77

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2023-02-24	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.96 to $633.41, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9) and (10) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $634.05 to $634.86, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $635.315 to $636.11, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $636.33 to $637.32, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $637.41 to $638.39, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $638.45 to $639.435, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $639.46 to $640.44, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $640.595 to $641.59, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $641.60 to $642.33, inclusive.
The option vested in four equal installments on February 24, 2017, 2018, 2019, and 2020.